ANC 0 3 0 3 B-clinical_variable
≥ 4 5 4 5 O
1,500 6 11 6 11 B-lower_bound
/ 11 12 11 12 I-lower_bound
mcL 12 15 12 15 I-lower_bound
( 16 17 16 17 O
1.5 17 20 17 20 B-lower_bound
x 21 22 21 22 I-lower_bound
10 23 25 23 25 I-lower_bound
^ 25 26 25 26 I-lower_bound
9 26 27 26 27 I-lower_bound
/ 27 28 27 28 I-lower_bound
L 28 29 28 29 I-lower_bound
) 29 30 29 30 O

AST 0 3 31 34 B-clinical_variable
/ 3 4 34 35 O
ALT 4 7 35 38 B-clinical_variable
≤ 8 9 39 40 O
2 10 11 41 42 B-upper_bound
times 12 17 43 48 I-upper_bound
upper 18 23 49 54 I-upper_bound
limit 24 29 55 60 I-upper_bound
of 30 32 61 63 I-upper_bound
normal 33 39 64 70 I-upper_bound
( 40 41 71 72 I-upper_bound
ULN 41 44 72 75 I-upper_bound
) 44 45 75 76 I-upper_bound

Abnormal 0 8 77 85 O
PET 9 12 86 89 B-treatment
scans 13 18 90 95 I-treatment
will 19 23 96 100 O
not 24 27 101 104 O
constitute 28 38 105 115 O
evaluable 39 48 116 125 O
disease 49 56 126 133 O
, 56 57 133 134 O
unless 58 64 135 141 O
verified 65 73 142 150 O
by 74 76 151 153 O
CT 77 79 154 156 B-treatment
scan 80 84 157 161 I-treatment
or 85 87 162 164 O
other 88 93 165 170 O
appropriate 94 105 171 182 O
imaging 106 113 183 190 O

All 0 3 191 194 O
patients 4 12 195 203 O
must 13 17 204 208 O
be 18 20 209 211 O
counseled 21 30 212 221 O
at 31 33 222 224 O
a 34 35 225 226 O
minimum 36 43 227 234 O
of 44 46 235 237 O
every 47 52 238 243 O
28 53 55 244 246 B-lower_bound
days 56 60 247 251 I-lower_bound
about 61 66 252 257 O
pregnancy 67 76 258 267 B-pregnancy
precautions 77 88 268 279 O
and 89 92 280 283 O
risks 93 98 284 289 O
of 99 101 290 292 O
fetal 102 107 293 298 O
exposure 108 116 299 307 O

Bilirubin 0 9 308 317 B-clinical_variable
≤ 10 11 318 319 O
2 12 13 320 321 B-upper_bound
times 14 19 322 327 I-upper_bound
ULN 20 23 328 331 I-upper_bound

Calculated 0 10 332 342 O
creatinine 11 21 343 353 B-clinical_variable
clearance 22 31 354 363 I-clinical_variable
by 32 34 364 366 O
Cockroft 35 43 367 375 B-clinical_variable
- 43 44 375 376 I-clinical_variable
Gault 44 49 376 381 I-clinical_variable
formula 50 57 382 389 I-clinical_variable
≥ 58 59 390 391 O
30 60 62 392 394 B-lower_bound
mL 63 65 395 397 I-lower_bound
/ 65 66 397 398 I-lower_bound
min 66 69 398 401 I-lower_bound

ECOG 0 4 402 406 B-clinical_variable
performance 5 16 407 418 I-clinical_variable
status 17 23 419 425 I-clinical_variable
0 24 25 426 427 B-lower_bound
- 25 26 427 428 O
2 26 27 428 429 B-upper_bound

HIV 0 3 430 433 B-chronic_disease
is 4 6 434 436 O
sensitive 7 16 437 446 O
to 17 19 447 449 O
antiretroviral 20 34 450 464 B-treatment
therapy 35 42 465 472 I-treatment

Histologically 0 14 473 487 O
confirmed 15 24 488 497 O
untreated 25 34 498 507 O
mantle 35 41 508 514 B-cancer
cell 42 46 515 519 I-cancer
lymphoma 47 55 520 528 I-cancer
( 56 57 529 530 I-cancer
MCL 57 60 530 533 I-cancer
) 60 61 533 534 I-cancer
, 61 62 534 535 O
with 63 67 536 540 O
documented 68 78 541 551 O
cyclin 79 85 552 558 O
D1 86 88 559 561 O
by 89 91 562 564 O
immunohistochemical 92 111 565 584 B-treatment
stains 112 118 585 591 I-treatment
and/or 119 125 592 598 O
t(11;14 126 133 599 606 O
) 133 134 606 607 O
by 135 137 608 610 O
cytogenetics 138 150 611 623 O
or 151 153 624 626 O
fluorescence 154 166 627 639 B-treatment
in 167 169 640 642 I-treatment
situ 170 174 643 647 I-treatment
hybridization 175 188 648 661 I-treatment
( 189 190 662 663 I-treatment
FISH 190 194 663 667 I-treatment
) 194 195 667 668 I-treatment

Males 0 5 669 674 B-gender
must 6 10 675 679 O
agree 11 16 680 685 O
to 17 19 686 688 O
abstain 20 27 689 696 O
from 28 32 697 701 O
donating 33 41 702 710 O
blood 42 47 711 716 O
, 47 48 716 717 O
semen 49 54 718 723 O
, 54 55 723 724 O
or 56 58 725 727 O
sperm 59 64 728 733 O
during 65 71 734 740 O
study 72 77 741 746 O
participation 78 91 747 760 O
and 92 95 761 764 O
for 96 99 765 768 O
at 100 102 769 771 O
least 103 108 772 777 O
28 109 111 778 780 B-lower_bound
days 112 116 781 785 I-lower_bound
after 117 122 786 791 O
discontinuation 123 138 792 807 O
from 139 143 808 812 O
protocol 144 152 813 821 B-treatment
treatment 153 162 822 831 I-treatment

Measurable 0 10 832 842 O
disease 11 18 843 850 B-chronic_disease
in 19 21 851 853 I-chronic_disease
the 22 25 854 857 I-chronic_disease
liver 26 31 858 863 I-chronic_disease
is 32 34 864 866 O
required 35 43 867 875 O
if 44 46 876 878 O
the 47 50 879 882 O
liver 51 56 883 888 O
is 57 59 889 891 O
the 60 63 892 895 O
only 64 68 896 900 O
site 69 73 901 905 O
of 74 76 906 908 O
lymphoma 77 85 909 917 B-cancer

Men 0 3 918 921 B-gender
must 4 8 922 926 O
agree 9 14 927 932 B-contraception_consent
to 15 17 933 935 I-contraception_consent
use 18 21 936 939 I-contraception_consent
a 22 23 940 941 I-contraception_consent
latex 24 29 942 947 I-contraception_consent
condom 30 36 948 954 I-contraception_consent
during 37 43 955 961 O
sexual 44 50 962 968 O
contact 51 58 969 976 O
with 59 63 977 981 O
a 64 65 982 983 O
female 66 72 984 990 B-gender
of 73 75 991 993 O
child 76 81 994 999 O
- 81 82 999 1000 O
bearing 82 89 1000 1007 O
potential 90 99 1008 1017 O
, 99 100 1017 1018 O
even 101 105 1019 1023 O
if 106 108 1024 1026 O
they 109 113 1027 1031 O
have 114 118 1032 1036 O
had 119 122 1037 1040 O
a 123 124 1041 1042 O
successful 125 135 1043 1053 O
vasectomy 136 145 1054 1063 B-treatment

Must 0 4 1064 1068 O
be 5 7 1069 1071 O
willing 8 15 1072 1079 O
to 16 18 1080 1082 O
take 19 23 1083 1087 O
effective 24 33 1088 1097 O
antiretroviral 34 48 1098 1112 B-treatment
therapy 49 56 1113 1120 I-treatment
if 57 59 1121 1123 O
indicated 60 69 1124 1133 O

Must 0 4 1134 1138 O
be 5 7 1139 1141 O
willing 8 15 1142 1149 O
to 16 18 1150 1152 O
take 19 23 1153 1157 O
effective 24 33 1158 1167 O
antiretroviral 34 48 1168 1182 B-treatment
therapy 49 56 1183 1190 I-treatment
, 56 57 1190 1191 O
if 58 60 1192 1194 O
indicated 61 70 1195 1204 O

Must 0 4 1205 1209 O
be 5 7 1210 1212 O
willing 8 15 1213 1220 O
to 16 18 1221 1223 O
take 19 23 1224 1228 O
prophylaxis 24 35 1229 1240 B-treatment
for 36 39 1241 1244 O
Pneumocystis 40 52 1245 1257 B-chronic_disease
jiroveci 53 61 1258 1266 I-chronic_disease
pneumonia 62 71 1267 1276 I-chronic_disease
( 72 73 1277 1278 I-chronic_disease
PCP 73 76 1278 1281 I-chronic_disease
) 76 77 1281 1282 I-chronic_disease
during 78 84 1283 1289 O
therapy 85 92 1290 1297 B-treatment
and 93 96 1298 1301 O
until 97 102 1302 1307 O
at 103 105 1308 1310 O
least 106 111 1311 1316 O
2 112 113 1317 1318 B-lower_bound
months 114 120 1319 1325 I-lower_bound
following 121 130 1326 1335 O
the 131 134 1336 1339 O
completion 135 145 1340 1350 O
of 146 148 1351 1353 O
therapy 149 156 1354 1361 O
or 157 159 1362 1364 O
until 160 165 1365 1370 O
the 166 169 1371 1374 O
CD4 170 173 1375 1378 B-clinical_variable
cells 174 179 1379 1384 I-clinical_variable
recover 180 187 1385 1392 O
to 188 190 1393 1395 O
over 191 195 1396 1400 O
250 196 199 1401 1404 B-lower_bound
cells 200 205 1405 1410 I-lower_bound
/ 205 206 1410 1411 I-lower_bound
mm³ 206 209 1411 1414 I-lower_bound
, 209 210 1414 1415 O
whichever 211 220 1416 1425 O
occurs 221 227 1426 1432 O
later 228 233 1433 1438 O

Negative 0 8 1439 1447 B-pregnancy
pregnancy 9 18 1448 1457 I-pregnancy
test 19 23 1458 1462 O

No 0 2 1463 1465 O
evidence 3 11 1466 1474 O
of 12 14 1475 1477 O
prior 15 20 1478 1483 O
malignancy 21 31 1484 1494 B-cancer
except 32 38 1495 1501 O
adequately 39 49 1502 1512 O
treated 50 57 1513 1520 O
non 58 61 1521 1524 B-cancer
- 61 62 1524 1525 I-cancer
melanoma 62 70 1525 1533 I-cancer
skin 71 75 1534 1538 I-cancer
cancer 76 82 1539 1545 I-cancer
, 82 83 1545 1546 O
in 84 86 1547 1549 B-cancer
situ 87 91 1550 1554 I-cancer
cervical 92 100 1555 1563 I-cancer
carcinoma 101 110 1564 1573 I-cancer
, 110 111 1573 1574 O
or 112 114 1575 1577 O
any 115 118 1578 1581 O
surgically 119 129 1582 1592 O
or 130 132 1593 1595 O
radiation 133 142 1596 1605 O
- 142 143 1605 1606 O
cured 143 148 1606 1611 O
malignancy 149 159 1612 1622 O
continuously 160 172 1623 1635 O
disease 173 180 1636 1643 O
free 181 185 1644 1648 O
for 186 189 1649 1652 O
≥ 190 191 1653 1654 O
5 192 193 1655 1656 B-lower_bound
years 194 199 1657 1662 I-lower_bound
so 200 202 1663 1665 O
as 203 205 1666 1668 O
not 206 209 1669 1672 O
to 210 212 1673 1675 O
interfere 213 222 1676 1685 O
with 223 227 1686 1690 O
interpretation 228 242 1691 1705 O
of 243 245 1706 1708 O
radiographic 246 258 1709 1721 O
response 259 267 1722 1730 O

No 0 2 1731 1733 O
history 3 10 1734 1741 O
of 11 13 1742 1744 O
AIDS 14 18 1745 1749 B-chronic_disease
- 18 19 1749 1750 O
defining 19 27 1750 1758 O
conditions 28 38 1759 1769 O

No 0 2 1770 1772 O
history 3 10 1773 1780 O
of 11 13 1781 1783 O
CD4 14 17 1784 1787 B-chronic_disease
prior 18 23 1788 1793 O
to 24 26 1794 1796 O
or 27 29 1797 1799 O
at 30 32 1800 1802 O
the 33 36 1803 1806 O
time 37 41 1807 1811 O
of 42 44 1812 1814 O
lymphoma 45 53 1815 1823 B-clinical_variable
diagnosis 54 63 1824 1833 I-clinical_variable
< 64 65 1834 1835 O
300 66 69 1836 1839 B-upper_bound
cells 70 75 1840 1845 I-upper_bound
/ 75 76 1845 1846 I-upper_bound
mm³ 76 79 1846 1849 I-upper_bound

No 0 2 1850 1852 O
prior 3 8 1853 1858 B-treatment
therapy 9 16 1859 1866 I-treatment
for 17 20 1867 1870 O
MCL 21 24 1871 1874 B-cancer
, 24 25 1874 1875 O
except 26 32 1876 1882 O
< 33 34 1883 1884 O
1 35 36 1885 1886 B-upper_bound
week 37 41 1887 1891 I-upper_bound
of 42 44 1892 1894 O
steroid 45 52 1895 1902 B-treatment
therapy 53 60 1903 1910 I-treatment
for 61 64 1911 1914 O
symptom 65 72 1915 1922 O
control 73 80 1923 1930 O

Patient 0 7 1931 1938 O
agrees 8 14 1939 1945 O
that 15 19 1946 1950 O
if 20 22 1951 1953 O
randomized 23 33 1954 1964 O
to 34 36 1965 1967 O
Arms 37 41 1968 1972 O
C 42 43 1973 1974 O
or 44 46 1975 1977 O
D 47 48 1978 1979 O
, 48 49 1979 1980 O
and 50 53 1981 1984 O
proceed 54 61 1985 1992 O
onto 62 66 1993 1997 O
Arms 67 71 1998 2002 O
G 72 73 2003 2004 O
or 74 76 2005 2007 O
H 77 78 2008 2009 O
, 78 79 2009 2010 O
they 80 84 2011 2015 O
must 85 89 2016 2020 O
register 90 98 2021 2029 O
into 99 103 2030 2034 O
the 104 107 2035 2038 O
mandatory 108 117 2039 2048 B-treatment
RevAssist 118 127 2049 2058 I-treatment
® 127 128 2058 2059 I-treatment
program 129 136 2060 2067 I-treatment
, 136 137 2067 2068 O
and 138 141 2069 2072 O
be 142 144 2073 2075 O
willing 145 152 2076 2083 O
and 153 156 2084 2087 O
able 157 161 2088 2092 O
to 162 164 2093 2095 O
comply 165 171 2096 2102 O
with 172 176 2103 2107 O
the 177 180 2108 2111 O
requirements 181 193 2112 2124 O
of 194 196 2125 2127 O
RevAssist 197 206 2128 2137 O

Patients 0 8 2138 2146 O
must 9 13 2147 2151 O
have 14 18 2152 2156 O
at 19 21 2157 2159 O
least 22 27 2160 2165 O
one 28 31 2166 2169 B-lower_bound
objective 32 41 2170 2179 O
measurable 42 52 2180 2190 O
disease 53 60 2191 2198 O
parameter 61 70 2199 2208 O

Patients 0 8 2209 2217 O
must 9 13 2218 2222 O
have 14 18 2223 2227 O
no 19 21 2228 2230 O
medical 22 29 2231 2238 O
contra 30 36 2239 2245 O
- 36 37 2245 2246 O
indications 37 48 2246 2257 O
to 49 51 2258 2260 O
, 51 52 2260 2261 O
and 53 56 2262 2265 O
be 57 59 2266 2268 O
willing 60 67 2269 2276 O
to 68 70 2277 2279 O
take 71 75 2280 2284 O
, 75 76 2284 2285 O
deep 77 81 2286 2290 B-treatment
vein 82 86 2291 2295 I-treatment
thrombosis 87 97 2296 2306 I-treatment
( 98 99 2307 2308 I-treatment
DVT 99 102 2308 2311 I-treatment
) 102 103 2311 2312 I-treatment
prophylaxis 104 115 2313 2324 I-treatment
as 116 118 2325 2327 O
all 119 122 2328 2331 O
patients 123 131 2332 2340 O
registering 132 143 2341 2352 O
to 144 146 2353 2355 O
the 147 150 2356 2359 O
lenalidomide 151 163 2360 2372 B-treatment
/ 163 164 2372 2373 O
rituximab 164 173 2373 2382 B-treatment
Arms 174 178 2383 2387 O
G 179 180 2388 2389 O
and 181 184 2390 2393 O
H 185 186 2394 2395 O
will 187 191 2396 2400 O
be 192 194 2401 2403 O
required 195 203 2404 2412 O
to 204 206 2413 2415 O
have 207 211 2416 2420 O
DVT 212 215 2421 2424 B-treatment
prophylaxis 216 227 2425 2436 I-treatment

Patients 0 8 2437 2445 O
must 9 13 2446 2450 O
not 14 17 2451 2454 O
be 18 20 2455 2457 O
participating 21 34 2458 2471 O
in 35 37 2472 2474 O
any 38 41 2475 2478 O
other 42 47 2479 2484 B-treatment
clinical 48 56 2485 2493 I-treatment
trial 57 62 2494 2499 I-treatment
or 63 65 2500 2502 O
taking 66 72 2503 2509 O
any 73 76 2510 2513 O
other 77 82 2514 2519 O
experimental 83 95 2520 2532 B-treatment
medications 96 107 2533 2544 I-treatment
within 108 114 2545 2551 O
14 115 117 2552 2554 B-upper_bound
days 118 122 2555 2559 I-upper_bound
prior 123 128 2560 2565 I-upper_bound
to 129 131 2566 2568 O
registration 132 144 2569 2581 O

Patients 0 8 2582 2590 O
must 9 13 2591 2595 O
not 14 17 2596 2599 O
have 18 22 2600 2604 O
NYHA 23 27 2605 2609 B-clinical_variable
Class 28 33 2610 2615 B-lower_bound
III 34 37 2616 2619 I-lower_bound
or 38 40 2620 2622 O
IV 41 43 2623 2625 B-upper_bound
heart 44 49 2626 2631 B-chronic_disease
failure 50 57 2632 2639 I-chronic_disease
, 57 58 2639 2640 O
uncontrolled 59 71 2641 2653 B-chronic_disease
angina 72 78 2654 2660 I-chronic_disease
, 78 79 2660 2661 O
severe 80 86 2662 2668 O
uncontrolled 87 99 2669 2681 O
ventricular 100 111 2682 2693 B-chronic_disease
arrhythmias 112 123 2694 2705 I-chronic_disease
, 123 124 2705 2706 O
or 125 127 2707 2709 O
electrocardiographic 128 148 2710 2730 B-treatment
evidence 149 157 2731 2739 O
of 158 160 2740 2742 O
acute 161 166 2743 2748 O
ischemia 167 175 2749 2757 B-chronic_disease

Patients 0 8 2758 2766 O
must 9 13 2767 2771 O
not 14 17 2772 2775 O
have 18 22 2776 2780 O
a 23 24 2781 2782 O
serious 25 32 2783 2790 O
medical 33 40 2791 2798 B-chronic_disease
or 41 43 2799 2801 O
psychiatric 44 55 2802 2813 B-chronic_disease
illness 56 63 2814 2821 I-chronic_disease
likely 64 70 2822 2828 O
to 71 73 2829 2831 O
interfere 74 83 2832 2841 O
with 84 88 2842 2846 O
study 89 94 2847 2852 O
participation 95 108 2853 2866 O

Patients 0 8 2867 2875 O
must 9 13 2876 2880 O
not 14 17 2881 2884 O
have 18 22 2885 2889 O
grade 23 28 2890 2895 B-lower_bound
2 29 30 2896 2897 I-lower_bound
or 31 33 2898 2900 O
greater 34 41 2901 2908 O
peripheral 42 52 2909 2919 B-clinical_variable
neuropathy 53 63 2920 2930 I-clinical_variable

Patients 0 8 2931 2939 O
must 9 13 2940 2944 O
not 14 17 2945 2948 O
have 18 22 2949 2953 O
hypersensitivity 23 39 2954 2970 O
to 40 42 2971 2973 O
bortezomib 43 53 2974 2984 B-treatment
, 53 54 2984 2985 O
boron 55 60 2986 2991 B-treatment
, 60 61 2991 2992 O
or 62 64 2993 2995 O
mannitol 65 73 2996 3004 B-treatment

Patients 0 8 3005 3013 O
on 9 11 3014 3016 O
Arms 12 16 3017 3021 O
G 17 18 3022 3023 O
and 19 22 3024 3027 O
H 23 24 3028 3029 O
without 25 32 3030 3037 O
a 33 34 3038 3039 O
history 35 42 3040 3047 O
of 43 45 3048 3050 O
a 46 47 3051 3052 O
thromboembolic 48 62 3053 3067 B-chronic_disease
event 63 68 3068 3073 I-chronic_disease
are 69 72 3074 3077 O
required 73 81 3078 3086 O
to 82 84 3087 3089 O
take 85 89 3090 3094 O
a 90 91 3095 3096 O
daily 92 97 3097 3102 O
aspirin 98 105 3103 3110 B-treatment
( 106 107 3111 3112 O
81 107 109 3112 3114 B-lower_bound
mg 110 112 3115 3117 I-lower_bound
or 113 115 3118 3120 O
325 116 119 3121 3124 B-upper_bound
mg 120 122 3125 3127 I-upper_bound
) 122 123 3127 3128 O
for 124 127 3129 3132 O
DVT 128 131 3133 3136 B-treatment
prophylaxis 132 143 3137 3148 I-treatment

Patients 0 8 3149 3157 O
randomized 9 19 3158 3168 O
to 20 22 3169 3171 O
Arms 23 27 3172 3176 O
G 28 29 3177 3178 O
or 30 32 3179 3181 O
H 33 34 3182 3183 O
who 35 38 3184 3187 O
have 39 43 3188 3192 O
a 44 45 3193 3194 O
history 46 53 3195 3202 O
of 54 56 3203 3205 O
a 57 58 3206 3207 O
thrombotic 59 69 3208 3218 B-chronic_disease
vascular 70 78 3219 3227 I-chronic_disease
event 79 84 3228 3233 I-chronic_disease
will 85 89 3234 3238 O
be 90 92 3239 3241 O
required 93 101 3242 3250 O
to 102 104 3251 3253 O
have 105 109 3254 3258 O
therapeutic 110 121 3259 3270 O
doses 122 127 3271 3276 O
of 128 130 3277 3279 O
low 131 134 3280 3283 B-treatment
- 134 135 3283 3284 I-treatment
molecular 135 144 3284 3293 I-treatment
weight 145 151 3294 3300 I-treatment
heparin 152 159 3301 3308 I-treatment
or 160 162 3309 3311 O
warfarin 163 171 3312 3320 B-treatment
to 172 174 3321 3323 O
maintain 175 183 3324 3332 O
an 184 186 3333 3335 O
INR 187 190 3336 3339 B-clinical_variable
between 191 198 3340 3347 O
2.0 199 202 3348 3351 B-lower_bound
- 203 204 3352 3353 O
3.0 205 208 3354 3357 B-upper_bound

Patients 0 8 3358 3366 O
who 9 12 3367 3370 O
are 13 16 3371 3374 O
unable 17 23 3375 3381 O
to 24 26 3382 3384 O
tolerate 27 35 3385 3393 O
aspirin 36 43 3394 3401 B-treatment
should 44 50 3402 3408 O
receive 51 58 3409 3416 O
low 59 62 3417 3420 B-treatment
molecular 63 72 3421 3430 I-treatment
weight 73 79 3431 3437 I-treatment
heparin 80 87 3438 3445 I-treatment
therapy 88 95 3446 3453 I-treatment
or 96 98 3454 3456 O
warfarin 99 107 3457 3465 B-treatment
treatment 108 117 3466 3475 I-treatment

Platelets 0 9 3476 3485 B-clinical_variable
≥ 10 11 3486 3487 O
100,000 12 19 3488 3495 B-lower_bound
/ 19 20 3495 3496 I-lower_bound
mcL 20 23 3496 3499 I-lower_bound
( 24 25 3500 3501 O
100 25 28 3501 3504 O
x 29 30 3505 3506 O
10 31 33 3507 3509 O
^ 33 34 3509 3510 O
9 34 35 3510 3511 O
/ 35 36 3511 3512 O
L 36 37 3512 3513 O
) 37 38 3513 3514 O

Women 0 5 3515 3520 B-gender
( 6 7 3521 3522 O
sexually 7 15 3522 3530 O
mature 16 22 3531 3537 O
female 23 29 3538 3544 B-gender
) 29 30 3544 3545 O
must 31 35 3546 3550 O
not 36 39 3551 3554 O
be 40 42 3555 3557 O
pregnant 43 51 3558 3566 B-pregnancy
or 52 54 3567 3569 O
breast 55 61 3570 3576 O
- 61 62 3576 3577 O
feeding 62 69 3577 3584 O

Women 0 5 3585 3590 B-gender
must 6 10 3591 3595 O
agree 11 16 3596 3601 O
to 17 19 3602 3604 O
abstain 20 27 3605 3612 O
from 28 32 3613 3617 O
donating 33 41 3618 3626 O
blood 42 47 3627 3632 O
during 48 54 3633 3639 O
study 55 60 3640 3645 O
participation 61 74 3646 3659 O
and 75 78 3660 3663 O
for 79 82 3664 3667 O
at 83 85 3668 3670 O
least 86 91 3671 3676 O
28 92 94 3677 3679 B-lower_bound
days 95 99 3680 3684 I-lower_bound
after 100 105 3685 3690 O
discontinuation 106 121 3691 3706 O
from 122 126 3707 3711 O
protocol 127 135 3712 3720 B-treatment
treatment 136 145 3721 3730 I-treatment

Women 0 5 3731 3736 B-gender
of 6 8 3737 3739 O
childbearing 9 21 3740 3752 O
potential 22 31 3753 3762 O
and 32 35 3763 3766 O
sexually 36 44 3767 3775 O
active 45 51 3776 3782 O
males 52 57 3783 3788 B-gender
use 58 61 3789 3792 B-contraception_consent
an 62 64 3793 3795 I-contraception_consent
accepted 65 73 3796 3804 I-contraception_consent
and 74 77 3805 3808 I-contraception_consent
effective 78 87 3809 3818 I-contraception_consent
method 88 94 3819 3825 I-contraception_consent
of 95 97 3826 3828 I-contraception_consent
contraception 98 111 3829 3842 I-contraception_consent

